Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Cole Mercer

UNBELIEVABLE: Switching between semaglutide and tirzepatide linked to 16 weight loss over two years - Caught on Camera

Adults who switched between semaglutide and tirzepatide lost an average of 16% of their body weight over two years, compared with 10.9% for those who stayed on the drug they started, according to a Cleveland Clinic analysis of 20,486 patients presented at ObesityWeek 2026. People who stopped treatment altogether lost 3.9%.

The findings, reported by Healio, come from health records rather than a randomized trial. They show an association between treatment paths and weight change, not proof that switching itself produced the extra loss. The work is a conference presentation and has not been published in a peer-reviewed journal.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.